Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)
Clinical trial NCT02513095 · COMPLETED
Trial details
- NCT number
- NCT02513095
- Sponsor
- Eagle Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2015-09-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.